Subhajit Chatterjee

About

Subh is a postdoctoral researcher at National Cancer Institute, NIH, USA. His current study involves evaluating the contributions of tumor viruses, including polyomaviruses and papillomaviruses, to the development of cancer using sequencing, bioinformatics and classical wet bench molecular biology. In his doctoral study, he worked on the development of a combination of different chemotherapeutic agents to target cancer cells by inhibiting angiogenesis and DNA repair pathways.

Employment

• National Cancer Institute Postdoctoral Researcher
  2022 - Present
• KIIT University Ph.D. Scholar
  2018 - 2022

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (22)

• Therapeutic-induced chromatin remodeling via AP-1/SWI-SNF enhances BK Polyomavirus replication in urothelial cells
  2026 DOI: 10.64898/2026.09.11.750935
  +Save
• Microhomology‐mediated repair machinery and its relationship with HPV‐mediated oncogenesis
  Journal of Medical Virology 2024 DOI: 10.1002/jmv.29674
  +Save
• Regulation of lipid and serine metabolism by the oncogene c-Myc
  International Review of Cell and Molecular Biology 2024 DOI: 10.1016/bs.ircmb.2024.03.005
  +Save
• Targeting signaling pathways in cancer stem cells: A potential approach for developing novel anti-cancer therapeutics
  2024 DOI: 10.1016/bs.ircmb.2024.01.001
  +Save
• Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
  Subarno Paul, Subhajit Chatterjee, Saptarshi Sinha +5 more
  Expert Opinion on Therapeutic Targets 2023 DOI: 10.1080/14728222.2023.2266572
  +Save
• Quinacrine inhibits cMET-mediated metastasis and angiogenesis in breast cancer stem cells
  Biswajit Das, Chinmayee Sethy, Subhajit Chatterjee +5 more
  Journal of Cell Communication and Signaling 2023 DOI: 10.1007/s12079-023-00756-9
  +Save
• Detection of Extensive Host-virus DNA Hybrids in Human Polyomavirus 7-Associated Pruritic Rash
  British Journal of Dermatology 2023 DOI: 10.1093/bjd/ljad002
  +Save
• Olaparib enhances the Resveratrol-mediated apoptosis in breast cancer cells by inhibiting the homologous recombination repair pathway
  Saptarshi Sinha, Subhajit Chatterjee, Subarno Paul +4 more
  Experimental Cell Research 2022 DOI: 10.1016/j.yexcr.2022.113338
  +Save
• Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
  Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul +4 more
  Journal of Cancer Research and Clinical Oncology 2022 DOI: 10.1007/s00432-022-04269-7
  +Save
• NIR irradiation enhances the apoptotic potentiality of Quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells
  Somya Ranjan Dash, Subhajit Chatterjee, Saptarshi Sinha +7 more
  Nanomedicine: Nanotechnology, Biology and Medicine 2021 DOI: 10.1016/j.nano.2021.102502
  +Save
• Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
  Subhajit Chatterjee, Saptarshi Sinha, Chanakya Nath Kundu
  European Journal of Pharmacology 2021 DOI: 10.1016/j.ejphar.2021.174516
  +Save
• Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly
  Sefinew Molla, Subhajit Chatterjee, Chinmayee Sethy +2 more
  DNA Repair 2021 DOI: 10.1016/j.dnarep.2021.103157
  +Save
• Nano formulated Resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages
  Rajalaxmi Pradhan, Subhajit Chatterjee, Krushna Chandra Hembram +3 more
  The Journal of Nutritional Biochemistry 2021 DOI: 10.1016/j.jnutbio.2021.108624
  +Save
• An Overview of Antioxidative Anticancer Therapies with Reference to the Cancer Stem Cells
  Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2021 DOI: 10.1007/978-981-16-1247-3_48-1
  +Save
• PARP inhibitor Veliparib (ABT-888) enhances the anti-angiogenic potentiality of Curcumin through deregulation of NECTIN-4 in oral cancer: Role of nitric oxide (NO)
  Subhajit Chatterjee, Saptarshi Sinha, Sefinew Molla +2 more
  Cellular Signalling 2020 DOI: 10.1016/j.cellsig.2020.109902
  +Save
• Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse
  Chinmayee Sethy, Kunal Goutam, Deepika Nayak +7 more
  Journal of Cancer Research and Clinical Oncology 2020 DOI: 10.1007/s00432-019-03055-2
  +Save
• Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells
  Subhajit Chatterjee, Chanakya Nath Kundu
  European Journal of Pharmacology 2020 DOI: 10.1016/j.ejphar.2020.173308
  +Save
• Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells
  Krushna Chandra Hembram, Somya Ranjan Dash, Biswajit Das +4 more
  Molecular pharmaceutics 2020 DOI: 10.1021/acs.molpharmaceut.0c00197
  +Save
• Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer
  Krushna Chandra Hembram, Subhajit Chatterjee, Chinmayee Sethy +5 more
  Molecular Pharmaceutics 2019 DOI: 10.1021/acs.molpharmaceut.9b00242
  +Save
• PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade
  Sefinew Molla, Krushna Chandra Hembram, Subhajit Chatterjee +4 more
  Pathology and Oncology Research 2019 DOI: 10.1007/s12253-019-00768-0
  +Save